Healthy donors needed to supply immune cells for future drug research
NCT ID NCT07663565
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects peripheral blood mononuclear cells (immune cells) from 200 healthy volunteers aged 18 to 40 using a process called apheresis. The cells will be used in the lab to study how they grow and function, helping researchers develop new drugs. No treatment or medication is given to participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help scientists develop new drugs or cell therapies by providing a source of immune cells for lab testing.
- What could go wrong
- This is an early-stage collection study, not a treatment trial. It does not test any drug or therapy on participants, so there is no direct health benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PBMCS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230001, China
-
The First Affiliated Hospital of Bengbu Medical University
SUSPENDEDBengbu, Anhui, 233000, China